Go Pro

This company has been marked as potentially delisted and may not be actively trading.

Premier (PINC) Competitors

Premier logo

PINC vs. OSCR, HQY, HNGE, HIMS, and PACS

Should you buy Premier stock or one of its competitors? Premier's main competitors and comparable companies include Oscar Health (OSCR), HealthEquity (HQY), Hinge Health (HNGE), Hims & Hers Health (HIMS), and PACS Group (PACS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Premier compare to Oscar Health?

Premier (NASDAQ:PINC) and Oscar Health (NYSE:OSCR) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

74.4% of Premier shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 1.0% of Premier shares are held by company insiders. Comparatively, 22.6% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Oscar Health had 10 more articles in the media than Premier. MarketBeat recorded 11 mentions for Oscar Health and 1 mentions for Premier. Oscar Health's average media sentiment score of 0.70 beat Premier's score of 0.00 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Premier
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Oscar Health
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Premier currently has a consensus price target of $28.25, indicating a potential downside of 42.66%. Oscar Health has a consensus price target of $33.90, indicating a potential upside of 14.18%. Given Oscar Health's stronger consensus rating and higher possible upside, analysts plainly believe Oscar Health is more favorable than Premier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Premier
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Oscar Health
1 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.31

Premier has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the broader market.

Oscar Health has a net margin of 3.60% compared to Premier's net margin of -3.28%. Oscar Health's return on equity of 38.45% beat Premier's return on equity.

Company Net Margins Return on Equity Return on Assets
Premier-3.28% 6.84% 3.48%
Oscar Health 3.60%38.45%6.76%

Premier has higher earnings, but lower revenue than Oscar Health. Premier is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier$1.00B4.05$20.27M-$0.27N/A
Oscar Health$11.70B0.78-$443.15M$1.4021.21

Summary

Oscar Health beats Premier on 15 of the 17 factors compared between the two stocks.

How does Premier compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

HealthEquity has a net margin of 17.36% compared to Premier's net margin of -3.28%. HealthEquity's return on equity of 15.33% beat Premier's return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.36% 15.33% 9.51%
Premier -3.28%6.84%3.48%

HealthEquity currently has a consensus price target of $112.20, suggesting a potential upside of 26.87%. Premier has a consensus price target of $28.25, suggesting a potential downside of 42.66%. Given HealthEquity's stronger consensus rating and higher possible upside, equities analysts plainly believe HealthEquity is more favorable than Premier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.92
Premier
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

HealthEquity has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

In the previous week, HealthEquity had 2 more articles in the media than Premier. MarketBeat recorded 3 mentions for HealthEquity and 1 mentions for Premier. HealthEquity's average media sentiment score of 0.69 beat Premier's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Premier
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

HealthEquity has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B5.57$215.20M$2.7731.93
Premier$1.00B4.05$20.27M-$0.27N/A

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 1.6% of HealthEquity shares are held by insiders. Comparatively, 1.0% of Premier shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

HealthEquity beats Premier on 16 of the 17 factors compared between the two stocks.

How does Premier compare to Hinge Health?

Premier (NASDAQ:PINC) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Premier has higher revenue and earnings than Hinge Health. Premier is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier$1.00B4.05$20.27M-$0.27N/A
Hinge Health$587.86M12.66-$528.26M$1.2872.08

74.4% of Premier shares are owned by institutional investors. 1.0% of Premier shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Premier presently has a consensus target price of $28.25, suggesting a potential downside of 42.66%. Hinge Health has a consensus target price of $103.71, suggesting a potential upside of 12.42%. Given Hinge Health's stronger consensus rating and higher possible upside, analysts plainly believe Hinge Health is more favorable than Premier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Premier
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hinge Health
0 Sell rating(s)
3 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.89

In the previous week, Hinge Health had 8 more articles in the media than Premier. MarketBeat recorded 9 mentions for Hinge Health and 1 mentions for Premier. Hinge Health's average media sentiment score of 0.32 beat Premier's score of 0.00 indicating that Hinge Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Premier
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hinge Health
2 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hinge Health has a net margin of 15.15% compared to Premier's net margin of -3.28%. Hinge Health's return on equity of 51.60% beat Premier's return on equity.

Company Net Margins Return on Equity Return on Assets
Premier-3.28% 6.84% 3.48%
Hinge Health 15.15%51.60%14.16%

Premier has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, indicating that its stock price is 38% more volatile than the broader market.

Summary

Hinge Health beats Premier on 14 of the 17 factors compared between the two stocks.

How does Premier compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

In the previous week, Hims & Hers Health had 45 more articles in the media than Premier. MarketBeat recorded 46 mentions for Hims & Hers Health and 1 mentions for Premier. Hims & Hers Health's average media sentiment score of 0.08 beat Premier's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
3 Very Positive mention(s)
4 Positive mention(s)
36 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Premier
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Premier has a net margin of -3.28% compared to Hims & Hers Health's net margin of -5.51%. Premier's return on equity of 6.84% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-5.51% -6.51% -1.20%
Premier -3.28%6.84%3.48%

Hims & Hers Health presently has a consensus price target of $32.43, suggesting a potential upside of 12.93%. Premier has a consensus price target of $28.25, suggesting a potential downside of 42.66%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than Premier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.13
Premier
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Hims & Hers Health has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B2.85$128.37M-$0.63N/A
Premier$1.00B4.05$20.27M-$0.27N/A

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 1.0% of Premier shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Hims & Hers Health has a beta of 2.42, indicating that its stock price is 142% more volatile than the broader market. Comparatively, Premier has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

Summary

Hims & Hers Health beats Premier on 10 of the 16 factors compared between the two stocks.

How does Premier compare to PACS Group?

PACS Group (NYSE:PACS) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

PACS Group has a net margin of 4.85% compared to Premier's net margin of -3.28%. PACS Group's return on equity of 29.55% beat Premier's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.85% 29.55% 5.23%
Premier -3.28%6.84%3.48%

74.4% of Premier shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 1.0% of Premier shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PACS Group has a beta of -0.13, meaning that its share price is 113% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

In the previous week, PACS Group had 5 more articles in the media than Premier. MarketBeat recorded 6 mentions for PACS Group and 1 mentions for Premier. PACS Group's average media sentiment score of 0.56 beat Premier's score of 0.00 indicating that PACS Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Premier
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PACS Group presently has a consensus target price of $58.80, indicating a potential upside of 36.19%. Premier has a consensus target price of $28.25, indicating a potential downside of 42.66%. Given PACS Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe PACS Group is more favorable than Premier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Premier
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

PACS Group has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.29$191.54M$1.7225.10
Premier$1.00B4.05$20.27M-$0.27N/A

Summary

PACS Group beats Premier on 13 of the 16 factors compared between the two stocks.

Get Premier News Delivered to You Automatically

Sign up to receive the latest news and ratings for PINC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PINC vs. The Competition

MetricPremierHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.33B$9.76B$7.34B$13.18B
Dividend Yield2.97%2.59%2.52%14.03%
P/E Ratio-182.4634.78274.7625.59
Price / Sales4.055.04613.3683.42
Price / Cash9.7424.1928.0235.00
Price / Book2.665.2110.536.44
Net Income$20.27M$315.68M$3.50B$360.47M

Premier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PINC
Premier
0.7195 of 5 stars
$49.27
+74.9%
$28.25
-42.7%
+77.3%$2.33B$1.00BN/A2,700
OSCR
Oscar Health
4.6232 of 5 stars
$29.93
-4.4%
$33.90
+13.3%
+61.0%$9.23B$11.70B21.352,305
HQY
HealthEquity
4.3149 of 5 stars
$92.71
-1.9%
$112.20
+21.0%
-8.6%$7.68B$1.31B33.532,814
HNGE
Hinge Health
3.7869 of 5 stars
$93.42
-1.1%
$103.71
+11.0%
+96.8%$7.54B$587.86M72.961,437
HIMS
Hims & Hers Health
2.2615 of 5 stars
$31.30
+6.7%
$32.43
+3.6%
-49.5%$7.31B$2.35BN/A2,442

Related Companies and Tools


This page (NASDAQ:PINC) was last updated on 9/28/2026 by MarketBeat.com Staff.
From Our Partners